Stocks in the news (cpf, nyt, ori, pr9, scb, shr, sisb, zen) 25.03.22
CPF sets 10% revenue growth target this year from Bt517b last year, to start exporting to Saudi Arabia in 2-3 months, after 5 plants with 7-8K tons got approval from Saudi FDA.
NYT sees recovery traffic at RO-RF pier on improving auto EXIM, expects BOI EV incentive boost exports volume.
Comment: The volumes from EV are not going to drive revenue or unit growth for the country. At best perhaps a substitute.
ORI TRIS upgrade CO, rating to BBB+ from BBB, revises outlook to stable from positive.
Comment: Isn’t this amusing?
PR9 denies report on Covid cluster among health care workers, so far 7 staffs caught virus and under isolation, no impact on operations.
SCB said its purchase of 51% stake in Bitkub is in compliance with BOT’s rules, sees little impact to its CAR which may just drop from 18.9% to 18.7%.
Comment: There have been rumours for the past few months that SCB found something in the DD of Bitkub that they don’t like. But I just don’t see them turning around and cancelling this deal…sunk cost is far too high for the management.
SHR sees 3 folds rise in 1Q22 rev on recovering tourism in the UK and Maldives, confident of 2X rose in FY22 revenue.
Comment: If you’re in Asia and never left during covid you wouldn’t realise that several parts of the world are happily living their lives.
SISB’s adding 2 campus from current 4, SISB Nonthaburi & SISB Rayong, target cod in FY23&24.
Comment: Regardless of the economic activity, parents are going to be willing to pay whatever they can afford for their kids to go to an international school in this country.
ZEN anticipates solid turnaround this year from improved QSR operation on absence of covid curbs, expects FY22 SSSG >20%, 30% sales growth above Bt3b.
Comment: I wonder how far the F&B players can push the increases in food prices to customers.